Drugs / Filgrastim-SD/01
last change Feb 2007 re-read 3 minutes ago

Filgrastim-SD/01

Developed for
non-small cell lung carcinoma
Investigated by
Amgen · Schwartzberg, Lee, M.D.

Trials 1

20022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT00050674 Nov 2001 → Feb 2007 non-small cell lung carcinoma Schwartzberg, Lee, M.D. Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Filgrastim-SD/01 ClinicalTrials.gov intervention name — accepted as the source's own label NCT00050674 ↗